NVDA

177.5

+0.1%↑

AVGO.US

314.06

-0.15%↓

ORCL

145.43

-0.58%↓

377.65

+3.17%↑

CSCO

80.4

+1.71%↑

NVDA

177.5

+0.1%↑

AVGO.US

314.06

-0.15%↓

ORCL

145.43

-0.58%↓

377.65

+3.17%↑

CSCO

80.4

+1.71%↑

NVDA

177.5

+0.1%↑

AVGO.US

314.06

-0.15%↓

ORCL

145.43

-0.58%↓

377.65

+3.17%↑

CSCO

80.4

+1.71%↑

NVDA

177.5

+0.1%↑

AVGO.US

314.06

-0.15%↓

ORCL

145.43

-0.58%↓

377.65

+3.17%↑

CSCO

80.4

+1.71%↑

NVDA

177.5

+0.1%↑

AVGO.US

314.06

-0.15%↓

ORCL

145.43

-0.58%↓

377.65

+3.17%↑

CSCO

80.4

+1.71%↑

Home・Stock List・Marqeta Inc (Class A)

Marqeta Inc (Class A)

Closed

SectorTechnology

4 0.76

Buy Sell

Overview

Share price change

24h

Current

Min

3.93

Max

4.04

Key metrics
By Trading Economics
Income	2.2M -1.4M
Sales	8.8M 172M
Profit margin	-0.81
Employees	938
EBITDA	-3.3M 3.5M

Recommendations
By TipRanks
Recommendations	Neutral
12 Months Forecast	+27.2% upside

Dividends
By Dow Jones
Next Earnings	5 May 2026

Market Stats
By TradingEconomics
Market Cap	-60M 1.8B
Previous open	3.24
Previous close	4

News Sentiment

By Acuity

34%

66%

96 / 375 Technology

Technical Score

By Trading Central

Confidence

Very Strong Bullish Evidence

3.975 / N/A Support & Resistance

Marqeta Inc (Class A) Chart

Past performance is not a reliable indicator of future results.

Related News

6 Apr 2026, 23:17 UTC

Earnings

Samsung Forecasts Record First-Quarter Operating Profit

6 Apr 2026, 23:00 UTC

Hot Stocks

Stocks to Watch: Health Insurers, Mawson, Owlet

6 Apr 2026, 22:13 UTC

Major Market Movers

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6 Apr 2026, 21:46 UTC

Acquisitions, Mergers, Takeovers

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6 Apr 2026, 17:09 UTC

Major Market Movers

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6 Apr 2026, 16:56 UTC

Major News Events

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6 Apr 2026, 14:47 UTC

Major Market Movers

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7 Apr 2026, 00:00 UTC

Major News Events

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6 Apr 2026, 23:58 UTC

Market Talk

Major News Events

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6 Apr 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6 Apr 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6 Apr 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6 Apr 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6 Apr 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6 Apr 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6 Apr 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6 Apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6 Apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 Apr 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 Apr 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6 Apr 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6 Apr 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6 Apr 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6 Apr 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6 Apr 2026, 18:36 UTC

Acquisitions, Mergers, Takeovers

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 Apr 2026, 17:59 UTC

Market Talk

Major News Events

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6 Apr 2026, 17:13 UTC

Acquisitions, Mergers, Takeovers

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6 Apr 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6 Apr 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 Apr 2026, 14:59 UTC

Earnings

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Peer Comparison

Price change

Marqeta Inc (Class A) Forecast

Price Target

By TipRanks

27.2% upside

12 Months Forecast

Average 5.05 USD 27.2%

High 6 USD

Low 4.25 USD

Based on 7 Wall Street analysts offering 12 month price targets forMarqeta Inc (Class A) - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

7 ratings

Buy

Hold

Sell

Based on 7 analysts giving stock ratings to Marqeta Inc (Class A) - Dist in the past 3 months.

Technical Score

By Trading Central

3.975 / N/ASupport & Resistance

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

96 / 375 Technology

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Marqeta Inc (Class A)

Marqeta, Inc. operates a cloud-based open application programming interface platform that delivers card issuing and transaction processing services. It offers its solutions in various verticals, including financial services, on-demand services, expense management, and e-commerce enablement, as well as buy now, pay later. Marqeta, Inc. was incorporated in 2010 and is headquartered in Oakland, California.